DK1853220T3 - Fremgangsmåde til fremstilling af tabletter indeholdende inflammationshæmmende non-steroid-lægemiddel, deres sammensætninger og medicinske anvendelse - Google Patents

Fremgangsmåde til fremstilling af tabletter indeholdende inflammationshæmmende non-steroid-lægemiddel, deres sammensætninger og medicinske anvendelse

Info

Publication number
DK1853220T3
DK1853220T3 DK06709907.7T DK06709907T DK1853220T3 DK 1853220 T3 DK1853220 T3 DK 1853220T3 DK 06709907 T DK06709907 T DK 06709907T DK 1853220 T3 DK1853220 T3 DK 1853220T3
Authority
DK
Denmark
Prior art keywords
inflammatory
compositions
tablets containing
medical uses
preparing tablets
Prior art date
Application number
DK06709907.7T
Other languages
English (en)
Inventor
Kirsty Sawicka
Jasmine Takhar
Paul Marshall
Michael Fanfarillo
Original Assignee
Reckitt Benckiser Healthcare (Uk) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1853220(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare (Uk) Ltd filed Critical Reckitt Benckiser Healthcare (Uk) Ltd
Application granted granted Critical
Publication of DK1853220T3 publication Critical patent/DK1853220T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06709907.7T 2005-03-01 2006-02-27 Fremgangsmåde til fremstilling af tabletter indeholdende inflammationshæmmende non-steroid-lægemiddel, deres sammensætninger og medicinske anvendelse DK1853220T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0504157A GB2423710A (en) 2005-03-01 2005-03-01 Lozenge production process
PCT/GB2006/000680 WO2006092569A1 (en) 2005-03-01 2006-02-27 Production process for nsaid-containing lozenges, their compositions, their medicinal use

Publications (1)

Publication Number Publication Date
DK1853220T3 true DK1853220T3 (da) 2017-11-13

Family

ID=34430399

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06709907.7T DK1853220T3 (da) 2005-03-01 2006-02-27 Fremgangsmåde til fremstilling af tabletter indeholdende inflammationshæmmende non-steroid-lægemiddel, deres sammensætninger og medicinske anvendelse

Country Status (21)

Country Link
US (2) US10328039B2 (da)
EP (3) EP2210587A1 (da)
JP (1) JP2008531664A (da)
KR (2) KR20140011422A (da)
CN (2) CN103156818A (da)
AU (1) AU2006219777B2 (da)
CA (1) CA2599861A1 (da)
DK (1) DK1853220T3 (da)
ES (2) ES2886323T3 (da)
GB (1) GB2423710A (da)
HU (1) HUE034872T2 (da)
MX (1) MX2007009275A (da)
MY (1) MY154770A (da)
PL (2) PL1853220T5 (da)
PT (1) PT1853220T (da)
RU (1) RU2403032C2 (da)
SG (1) SG161201A1 (da)
SI (2) SI1853220T2 (da)
TW (1) TWI372065B (da)
WO (1) WO2006092569A1 (da)
ZA (1) ZA200706067B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090104236A1 (en) * 2007-10-18 2009-04-23 Pharmaceutics International, Inc. Pharmaceutical solid hybrids
GB201215988D0 (en) * 2012-09-07 2012-10-24 Reckitt Benckiser Healthcare Int Ltd Pharmaceutical compositions comprising flurbiprofen
US9914968B2 (en) 2012-09-26 2018-03-13 Cepheid Honeycomb tube
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20220313710A1 (en) * 2019-08-22 2022-10-06 Applied Biological Laboratories, Inc. Compositions and methods using non-steroidal anti-inflammatory drugs

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084864A (en) 1964-02-06 1967-09-27 Merck & Co Inc Medicated lozenges
US5071643A (en) † 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
GB9523833D0 (en) 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU8107998A (en) 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
CA2419592A1 (en) * 2000-08-18 2002-02-28 Pharmacia Corporation Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
US6689382B2 (en) 2002-05-15 2004-02-10 Procaps S.A. Soft shell gelatin capsules containing non-steroidal anti-inflammatories
US20070190153A1 (en) 2004-03-05 2007-08-16 Jonathan Farber Delivery systems for non-steroidal anti-inflammatory drugs (nsaids)

Also Published As

Publication number Publication date
US20080206326A1 (en) 2008-08-28
GB2423710A (en) 2006-09-06
RU2007136106A (ru) 2009-04-10
ES2647488T5 (es) 2023-08-09
RU2403032C2 (ru) 2010-11-10
PL1853220T3 (pl) 2018-01-31
ES2647488T3 (es) 2017-12-21
MY154770A (en) 2015-07-15
PL1853220T5 (pl) 2023-08-07
JP2008531664A (ja) 2008-08-14
EP1853220B2 (en) 2023-03-29
KR20070110053A (ko) 2007-11-15
AU2006219777A1 (en) 2006-09-08
SI1853220T1 (sl) 2017-12-29
PL3284458T3 (pl) 2021-12-13
CA2599861A1 (en) 2006-09-08
ZA200706067B (en) 2008-09-25
SG161201A1 (en) 2010-05-27
ES2886323T3 (es) 2021-12-17
EP3284458A1 (en) 2018-02-21
EP3284458B1 (en) 2021-06-16
SI1853220T2 (sl) 2023-07-31
US20190307711A1 (en) 2019-10-10
EP1853220B1 (en) 2017-08-16
GB0504157D0 (en) 2005-04-06
EP2210587A1 (en) 2010-07-28
TW200716199A (en) 2007-05-01
SI3284458T1 (sl) 2021-11-30
PT1853220T (pt) 2017-11-17
AU2006219777B2 (en) 2010-07-01
KR20140011422A (ko) 2014-01-28
CN101132762A (zh) 2008-02-27
US10933040B2 (en) 2021-03-02
EP1853220A1 (en) 2007-11-14
KR101358687B1 (ko) 2014-02-07
WO2006092569A1 (en) 2006-09-08
ES2647488T4 (es) 2024-01-16
MX2007009275A (es) 2007-09-19
CN103156818A (zh) 2013-06-19
HUE034872T2 (hu) 2018-03-28
US10328039B2 (en) 2019-06-25
TWI372065B (en) 2012-09-11

Similar Documents

Publication Publication Date Title
DK1909764T3 (da) Farmaceutisk sammensætninger omfattende levetiracetam og fremgangsmåde til deres fremstilling
DK2024352T3 (da) Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling
DK1928503T3 (da) Fremgangsmåde til fremstilling af oprensede lægemiddelkonjugater
DK2178881T3 (da) Hidtil ukendte 6-triazolopyridazin-sulfanyl-benzothiazol- og -benzimidazolderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske sammensætninger og hidtil ukendt anvendelse som met-hæmmere
IL228402A0 (en) Nitro-cyclic compounds, their pharmaceutical preparations and their uses
DK1913001T3 (da) (r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf
DK1863812T3 (da) Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
DK2442107T3 (da) Haptener, haptenkonjugater, sammensætninger deraf og fremgangsmåde til deres fremstilling og anvendelse
DK1695710T3 (da) Krystallinsk betad-form af ivabradinhydrochlorid, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende denne
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DK2044076T3 (da) Fremgangsmåde til fremstilling af asenapin og intermediatprodukter, som anvendes i fremgangsmåden
DK2036892T3 (da) 1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1752443T3 (da) Ny krystallinsk form V af agomelatin, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dette
NO20052683D0 (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
DK3072507T3 (da) Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
DK1953161T3 (da) Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK2041069T3 (da) Benzylaminer, fremgangsmåde til fremstilling deraf og deres anvendelse som anti-inflammatoriske midler
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
DK2172207T3 (da) Farmaceutisk sammensætning til behandling af diabetes og fremgangsmåde til fremstilling heraf
DK2158194T3 (da) Derivater af 7-alkynyl-1,8-naphtyridoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
DK1718340T3 (da) Nye effektorkonjugater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DK1707564T3 (da) Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1979321T3 (da) Nye pyridinylaminoalkylen- og pyridinyloxyalkylen-cyclopropanaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dissse